Nemaura Medical (NMRD) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NMRD vs. AFIB, SONX, UTRS, MOTS, VIVE, DRTSW, ANZUW, ATAKW, BBLGW, and HSCSWShould you be buying Nemaura Medical stock or one of its competitors? The main competitors of Nemaura Medical include Acutus Medical (AFIB), Sonendo (SONX), Minerva Surgical (UTRS), Motus GI (MOTS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), and Heart Test Laboratories (HSCSW). These companies are all part of the "medical equipment" industry. Nemaura Medical vs. Its Competitors Acutus Medical Sonendo Minerva Surgical Motus GI Viveve Medical Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics Heart Test Laboratories Acutus Medical (NASDAQ:AFIB) and Nemaura Medical (NASDAQ:NMRD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and institutional ownership. Does the media prefer AFIB or NMRD? In the previous week, Acutus Medical had 1 more articles in the media than Nemaura Medical. MarketBeat recorded 1 mentions for Acutus Medical and 0 mentions for Nemaura Medical. Acutus Medical's average media sentiment score of 0.00 equaled Nemaura Medical'saverage media sentiment score. Company Overall Sentiment Acutus Medical Neutral Nemaura Medical Neutral Is AFIB or NMRD more profitable? Nemaura Medical has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Nemaura Medical's return on equity of 0.00% beat Acutus Medical's return on equity.Company Net Margins Return on Equity Return on Assets Acutus Medical-272.74% -311.64% -11.57% Nemaura Medical N/A N/A N/A Do insiders and institutionals hold more shares of AFIB or NMRD? 56.9% of Acutus Medical shares are owned by institutional investors. Comparatively, 4.4% of Nemaura Medical shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by company insiders. Comparatively, 40.4% of Nemaura Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has better valuation and earnings, AFIB or NMRD? Nemaura Medical has lower revenue, but higher earnings than Acutus Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAcutus Medical$7.16M0.00-$81.66MN/AN/ANemaura Medical$3.02K0.00-$14.14M-$0.39N/A Which has more risk & volatility, AFIB or NMRD? Acutus Medical has a beta of -0.62, suggesting that its stock price is 162% less volatile than the S&P 500. Comparatively, Nemaura Medical has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500. SummaryNemaura Medical beats Acutus Medical on 6 of the 9 factors compared between the two stocks. Get Nemaura Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NMRD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NMRD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NMRD vs. The Competition Export to ExcelMetricNemaura MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$4K$81.26M$5.74B$9.56BDividend YieldN/AN/A4.53%4.08%P/E Ratio0.0011.0130.4525.16Price / SalesN/A104.26392.5887.64Price / CashN/A18.4137.0358.50Price / BookN/A7.408.956.21Net Income-$14.14M-$26.48M$3.26B$265.38M Nemaura Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NMRDNemaura Medical1.234 of 5 starsN/AN/AN/A$4K$3.02K0.0040AFIBAcutus MedicalN/A$0.00flatN/A-98.2%$15K$7.16M0.00340News CoverageGap UpSONXSonendo0.9255 of 5 stars$0.02flatN/A-51.9%$9K$44.40M0.00250News CoverageGap UpUTRSMinerva SurgicalN/AN/AN/AN/A$1K$51.69M0.00160MOTSMotus GI0.1379 of 5 stars$0.00flatN/AN/A$1K$319K0.0030High Trading VolumeVIVEViveve MedicalN/A$0.00flatN/AN/A$1K$6.83M0.0070DRTSWAlpha Tau MedicalN/A$0.26-3.7%N/A+52.1%$0.00N/A0.0080Positive NewsGap UpANZUWAnzu Special Acquisition Corp IN/A$0.04flatN/A-61.1%$0.00N/A0.002ATAKWAurora Technology AcquisitionN/A$0.02+38.6%N/A-50.0%$0.00N/A0.00N/AGap UpBBLGWBone BiologicsN/A$10.79-20.1%N/AN/A$0.00N/A0.002Gap DownHSCSWHeart Test LaboratoriesN/A$0.15+36.4%N/A+384.3%$0.00$4.35K0.0010Gap Up Related Companies and Tools Related Companies AFIB Competitors SONX Competitors UTRS Competitors MOTS Competitors VIVE Competitors DRTSW Competitors ANZUW Competitors ATAKW Competitors BBLGW Competitors HSCSW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NMRD) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nemaura Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nemaura Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access